1. Home
  2. INN vs DCTH Comparison

INN vs DCTH Comparison

Compare INN & DCTH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • INN
  • DCTH
  • Stock Information
  • Founded
  • INN 2010
  • DCTH 1988
  • Country
  • INN United States
  • DCTH United States
  • Employees
  • INN N/A
  • DCTH N/A
  • Industry
  • INN Real Estate Investment Trusts
  • DCTH Medical/Dental Instruments
  • Sector
  • INN Real Estate
  • DCTH Health Care
  • Exchange
  • INN Nasdaq
  • DCTH Nasdaq
  • Market Cap
  • INN 503.9M
  • DCTH 518.0M
  • IPO Year
  • INN 2011
  • DCTH N/A
  • Fundamental
  • Price
  • INN $4.35
  • DCTH $14.84
  • Analyst Decision
  • INN
  • DCTH Strong Buy
  • Analyst Count
  • INN 0
  • DCTH 4
  • Target Price
  • INN N/A
  • DCTH $22.75
  • AVG Volume (30 Days)
  • INN 1.0M
  • DCTH 408.9K
  • Earning Date
  • INN 04-30-2025
  • DCTH 05-08-2025
  • Dividend Yield
  • INN 7.31%
  • DCTH N/A
  • EPS Growth
  • INN N/A
  • DCTH N/A
  • EPS
  • INN 0.20
  • DCTH N/A
  • Revenue
  • INN $728,119,000.00
  • DCTH $53,850,000.00
  • Revenue This Year
  • INN $3.26
  • DCTH $128.78
  • Revenue Next Year
  • INN $2.54
  • DCTH $54.07
  • P/E Ratio
  • INN $21.61
  • DCTH N/A
  • Revenue Growth
  • INN N/A
  • DCTH 1068.87
  • 52 Week Low
  • INN $3.57
  • DCTH $5.30
  • 52 Week High
  • INN $7.22
  • DCTH $16.97
  • Technical
  • Relative Strength Index (RSI)
  • INN 49.31
  • DCTH 69.96
  • Support Level
  • INN $4.09
  • DCTH $11.38
  • Resistance Level
  • INN $4.42
  • DCTH $12.49
  • Average True Range (ATR)
  • INN 0.18
  • DCTH 0.65
  • MACD
  • INN 0.10
  • DCTH 0.33
  • Stochastic Oscillator
  • INN 88.46
  • DCTH 75.22

About INN Summit Hotel Properties Inc.

Summit Hotel Properties Inc is a U.S.-based hotel investment company focusing on select-service hotels in the upscale and upper-midscale properties in the U.S. Substantially all of Summit's assets are held and operated by its Operating Partnership, Summit Hotel OP, LP, in which the company holds general and limited partnership interests. The firm has one segment in activities related to investing in real estate. Summit's revenue streams include Room and Other hotel operations revenue. Room comprises the majority of total revenues. The firm's hotels are located in various markets, such as corporate offices, retail centers, airports, state capitols, convention centers, and leisure attractions. Summit's hotels operate under brands, including Marriott, Hilton, Hyatt, and Holiday Inn.

About DCTH Delcath Systems Inc.

Delcath Systems Inc is an oncology company. It is focused on the treatment of primary and metastatic liver cancers. The firm's product, Melphalan Hydrochloride for Injection along with the Delcath Hepatic Delivery System, or Melphalan/HDS, is a drug and device combination product, designed to administer high-dose chemotherapy to the liver while controlling systemic exposure and associated side effects.

Share on Social Networks: